Encainide-induced encephalopathy in a patient with chronic renal failure.
A report of encainide-induced encephalopathy in a patient with chronic renal failure is presented. Drug encephalopathy has been previously reported with various agents, but not with encainide. The patient improved after withdrawal of encainide.
Tartini
A
A
Department of Internal Medicine, St Joseph's Hospital and Medical Center, Seton Hall University, School of Graduate Medical Education, Paterson, NJ 07503.
Kesselbrenner
M
M
D000368:Aged; D000813:Anilides / Q000009:adverse effects* / Q000493:pharmacokinetics; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000493:pharmacokinetics; D001145:Arrhythmias, Cardiac / Q000150:complications / Q000188:drug therapy; D016700:Encainide; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000378:metabolism; D019966:Substance-Related Disorders / Q000209:etiology*
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D016700:Encainide